FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:331-333 January 25, 2007 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Clinical practice guidelines are systematically developed statements that aim to help physicians and patients reach the best health care decisions. Good guidelines have many attributes, including validity, reliability, reproducibility, clinical applicability and flexibility, clarity, development through a multidisciplinary process, scheduled reviews, and documentation.¹ More than 2000 guidelines are currently represented in the National Guideline Clearinghouse (www.guideline.gov). Medical specialty societies are their most common sponsors.

Guidelines rely on both evidence and opinion; they are neither infallible nor a substitute for clinical judgment. They do, however, go beyond systematic reviews to recommend what should and should not be done in . . . [Full Text of this Article]

Source Information

Dr. Steinbrook (rsteinbrook@attglobal.net) is a national correspondent for the Journal.

This article has been cited by other articles:

• Holloway, R. G., Mooney, C. J., Getchius, T.S.D., Edlund, W. S., Miyasaki, J. O. (2008). Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Neurology 71: 57-63 [Abstract] [Full Text]  
• Stricker, R. B., Johnson, L., Halperin, J., Bever, C.T., Belman, A.L., Dotevall, L., Gronseth, G., Krupp, L., Logigian, E., Shapiro, E.D., Wormser, G.P. (2008). PRACTICE PARAMETER: TREATMENT OF NERVOUS SYSTEM LYME DISEASE (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY. Neurology 70: 1719-1720 [Full Text]  
• Dhalla, I. MD, Laupacis, A. MD MSc (2008). Moving from opacity to transparency in pharmaceutical policy. CMAJ 178: 428-431 [Full Text]  
• Tonks, A. (2007). Too much of a good thing. BMJ 334: 978-980 [Full Text]  
• Camilleri, M., Cortese, D. A. (2007). Managing Conflict of Interest in Clinical Practice. Mayo Clin Proc. 82: 607-614 [Full Text]  
• Coyne, D. W. (2007). Use of Epoetin in Chronic Renal Failure. JAMA 297: 1713-1716 [Full Text]  
• Durie, B. G. M., IMWG, (2007). Use of Bisphosphonates in Multiple Myeloma: IMWG Response to Mayo Clinic Consensus Statement. Mayo Clin Proc. 82: 516-517 [Full Text]  
• Kassirer, J. P. (2007). Stacking the Deck. CJASN 2: 212-212 [Full Text]